Recent advances in the genetics of epilepsy: Insights from human and animal studies

Epilepsia

Volumn 40, Issue 10, 1999, Pages 1329-1352

  Prasad, Asuri N ^a   Prasad, Chitra ^a   Stafstrom, Carl E ^a,b,c  

^a New Janeway Childrens Health and Rehabilitation Centre   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Animal models; Epilepsy; Genetics; Human; Pathophysiology

Indexed keywords

BIOTINIDASE; PYRIDOXINE;

ABSENCE; AGYRIA; BENIGN CHILDHOOD EPILEPSY; DOWN SYNDROME; DRUG DEPENDENCE; ENZYME DEFICIENCY; EPILEPSY; FEBRILE CONVULSION; FRAGILE X SYNDROME; FRONTAL LOBE EPILEPSY; GENE MAPPING; GENETIC ANALYSIS; HAPPY PUPPET SYNDROME; HYPERGLYCEMIA; INHERITANCE; LACTIC ACIDOSIS; LIPOFUSCINOSIS; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; REVIEW; SIALIDOSIS; TEMPORAL LOBE EPILEPSY; TUBEROUS SCLEROSIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; MICE; MODELS, GENETIC; MOLECULAR BIOLOGY;

EID: 0032820822     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb02004.x     Document Type: Review

References (296)

1. Delgado-Escueta AV, Serratosa JM, Liu A, et al. Progress in mapping human epilepsy genes. Epilepsia 1994;35(suppl 1):S29-40.
2. Berkovic SF, Scheffer IE. Genetics of human partial epilepsy. Curr Opin Neurol 1997;10:110-4.
3. Treiman L, Treiman D. Genetic aspects of epilepsy. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. 2nd ed. Baltimore: Williams & Wilkins, 1997:151-64.
4. Berkovic SF, Scheffer IE. Epilepsies with single gene inheritance. Brain Dev 1997;19:13-8.
5. Dichter M, Buchhalter J. The genetic epilepsies. In: Rosenberg R, Prusiner S, DiMauro S, Barchi R, eds. The molecular and genetic-basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann, 1997;757-83.
6. McNamara JO. Genetics of epilepsy. In: Martin JB, ed. Molecular neurobiology. New York: Scientific American Inc, 1998:75-93.
7. Allen KM, Walsh C. Shaking down new epilepsy genes. Nat Med 1996;2:516-8.
8. Noebels JL. Targeting epilepsy genes. Neuron 1996;16:241-4.
9. Doose H. Genetic EEG traits in the pathogenesis of the epilepsies. J Epilepsy 1997;10:97-110.
10. Pedley TA. EEG traits. In: Engel J, Pedley TA, eds. Epilepsy: a Comprehensive textbook. Philadelphia: Lippincott-Raven, 1998: 185-96.
11. 10a. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos Press, 1990.
12. Lander ES, Schork NJ, Genetic dissection of complex traits. Science 1994;265:2037-48.
13. Whitehouse WP, Rees M, Curtis D, et al. Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: no evidence for an epilepsy locus in the HLA region. Am J Hum Genet 1993;53:652-62.
14. Lewis TB, Leach RJ, Ward K, O'Connell P, Ryan SG. Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet 1993;53:670-5.
15. 13a. Berkovic SF. Epilepsy genes and the genetics of epilepsy syndromes: the promise of new therapies based on genetic knowledge. Epilepsia 1997;38(suppl 9):S32-6.
16. Doose H, Gerken H. On the genetics of EEG-anomalies in childhood. IV. Photoconvulsive reaction. Neuropediatrie 1973;4: 162-71.
17. Naquet R, Silva-Barrat C, Menini C. Reflex epilepsy in the Papio papio baboon, particularly photosensitive epilepsy. Ital J Neurol Sci 1995;16:119-25.
18. Berkovic SF, Scheffer IE. Febrile seizures: genetics and relationship to other epilepsy syndromes. Curr Opin Neurol 1998;11: 129-34.
19. O'Donnell DM, Zoghbi HY. Trinucleotide repeat disorders in pediatrics. Curr Opin Pediatr 1995;7:715-25.
20. Bates G, Lehrach H. Trinucleotide repeat expansions and human genetic disease. Bioessays 1994;16:277-84.
21. Musumeci SA, Ferri R, Elia M, Colognola RM, Bergonzi P, Tassinari CA. Epilepsy and fragile X syndrome: a follow-up study. Am J Med Genet 1991;38:511-3.
22. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 1994;6:9-13.
23. Lalioti MD, Scott HS, Buresi C, et al. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 1997;386:847-51.
24. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
25. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 389-99.
26. Zhao LP, Hsu L, Davidov O, Potter J, Elston RC, Prentice RL. Population-based family study designs: an interdisciplinary research framework for genetic epidemiology. Genet Epidemiol 1997;14:365-88.
27. Sander T, Kretz R, Schulz H, et al. Replication analysis of a putative susceptibility locus (EGI) for idiopathic generalized epilepsy on chromosome 8q24. Epilepsia 1998;39:715-20.
28. 1A-voltage-dependent calcium channel (CACN1A4) is not a candidate for causing common subtypes of idiopathic generalized epilepsy. Epilepsy Res 1998;29:115-22.
29. Collins FS. Of needles and haystacks: finding human disease genes by positional cloning. Clin Res 1991;39:615-23.
30. Noebels JL. Single locus mutations in mice expressing generalized spike-wave absence epilepsies. Ital J Neurol Sci 1995;16: 107-11.
31. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet 1995;9:347-50.
32. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-9.
33. Charlier C, Singh NA, Ryan SG, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998;18:53-5.
34. McNamara JO. Identification of genetic defect of an epilepsy: strategies for therapeutic advances. Epilepsia 1994;35(suppl 1): S51-7.
35. Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998;43:435-45.
36. Delgado-Escueta AV, Greenberg D, Weissbecker K, et al. Gene mapping in the idiopathic generalized epilepsies: juvenile myoclonic epilepsy, childhood absence epilepsy, epilepsy with grand mal seizures, and early childhood myoclonic epilepsy. Epilepsia 1990;31(suppl 3):S19-29.
37. Greenberg DA. There is more than one way to collect data for linkage analysis: what a study of epilepsy can tell us about linkage strategy for psychiatric disease. Arch Gen Psychiatry 1992; 49:745-50.
38. Greenberg DA, Delgado-Escueta AV, Widelitz H, et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet 1988;31:185-92.
39. Dumer M, Sander T, Greenberg DA, Johnson K, Beck-Mannagetta G, Janz D. Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology 1991;41:1651-5.
40. Delgado-Escueta AV, Greenberg DA, Treiman L, et al. Mapping the gene for juvenile myoclonic epilepsy. Epilepsia 1989; 30(suppl 4):S8-18.
41. Delgado-Escueta AV, Greenberg DA. Mapping genes in juvenile myoclonic epilepsy. Rev Neurol (Paris) 1987;143:351-62.
42. Elmslie FV, Williamson MP, Rees M, et al. Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region. Am J Hum Genet 1996;59:653-63.
43. Elmslie FV, Rees M, Williamson MP, et al. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 1997;6:1329-34.
44. Zara F, Blanchi A, Avanzini G, et al. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum MolI Genet 1995; 4:1201-7.
45. Fong GCY, Shah PU, Gee MN, et al. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24. Am J Hum Genet 1998;63:1117-29.
46. Buoni S, Grosso S, Di Cosmo G, Di Bartolo RM, Di Marco V, Fois A. Segregation analysis in typical absence epilepsy. J Child Neurol 1998;13:89-93.
47. Sander T, Hildmann T, Janz D, et al. The phenotypic spectrum related to the human epilepsy susceptibility gene "EJM1." Ann Neurol 1995;38:210-7.
48. Sander T, Hildmann T, Kretz R, et al. Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphism. Am J Med Genet 1997;74:416-21.
49. Buchhalter JR. Animal models of inherited epilepsy. Epilepsia 1993;34(suppl 3):S31-41.
50. Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 1998;55:27-57.
51. Caddick SJ, Hosford DA. The role of GABA(B) mechanisms in animal models of absence seizures. Mol Neurobiol 1996;13:23-32.
52. Aizawa M, Ito Y, Fukuda H. Pharmacological profiles of generalized absence seizures in lethargic, stargazer and gamma-hydroxybulyrate-treated model mice. Neurosci Res 1997;29:17-25.
53. Helekar SA, Noebels JL. A burst-dependent hippocampal excitability defect elicited by potassium at the developmental onset of spike-wave seizures in the Tottering mutant. Dev Brain Res 1992;65:205-10.
54. Fletcher CF, Lutz CM, O'Sullivan TN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996;87:607-17.
55. 2+ channel gene CACNL1A4. Cell 1996;87: 543-52.
56. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (1h) mouse. Cell 1997;88:385-92.
57. Lin FH, Cao Z, Hosford DA. Increased number of GABA(B) receptors in the lethargic (1h/1h) mouse model of absence epilepsy. Brain Res 1993;608:101-6.
58. Di Pasquale E, Keegan KD, Noebels JL. Increased excitability and inward rectification in layer V cortical pyramidal neurons in the epileptic mutant mouse Stargazer. J Neurophysiol 1997;77: 621-31.
59. 2+-channel gamma subunit. Nat Genet 1998;19:340-7.
60. Cox GA, Lutz CM, Yang CL, et al. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 1997;91: 139-48.
61. Cunniff C, Wiedlin N, Jones KL. Autosomal dominant benign neonatal seizures. Am J Med Genet 1988;30:963-6.
62. Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993;43:1355-60.
63. Andrews PI, Stafstrom CE. Ictal EEG findings in an infant with benign familial neonatal convulsions. J Epilepsy 1993;6:174-9.
64. Hirsch E, Velez A, Sellal F, et al. Electroclinical signs of benign neonatal familial convulsions. Ann Neurol 1993;34:835-41.
65. Plouin P. Benign familial neonatal convulsions and benign idiopathic convulsions. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1998:2247-55.
66. Leppert M, Anderson VE, Quattlebaum T, et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989;337:647-8.
67. Lewis TB, Shevell MI, Andermann E, Ryan SG, Leach RJ. Evidence of a third locus for benign familial convulsions. J Child Neurol 1996;11:211-4.
68. Biervert C, Schroeder BC, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-6.
69. + channels causes epilepsy. Nature 1998;396:687-90.
70. Pryor DS, Don N, Macourt DC. Fifth day fits: a syndrome of neonatal convulsions. Arch Dis Child 1981;56:753-8.
71. North KN, Storey GN, Henderson-Smart DJ. Fifth day fits in the newborn. Aust Paediatr J 1989;25:284-7.
72. Vigevano F, Fusco L, Di Capua M, Ricci S, Sebastianelli R, Lucchini P. Benign infantile familial convulsions. Eur J Pediatr 1992;151:608-12.
73. Hirvasniemi A, Lang H, Lehesjoki AE, Leisti J. Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet 1994;31:177-82.
74. Lang AH, Hirvasniemi A, Siivola J. Neurophysiological findings in the Northern epilepsy syndrome. Acta Neurol Scand 1997;95: 1-8.
75. Tahvanainen E, Ranta S, Hirvasniemi A, et al. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. Proc Natl Acad Sci USA 1994;91:7267-70.
76. Ranta S, Lehesjoki AE, de Fatima Bonaldo M, et al. High-resolution mapping and transcript identification at the progressive epilepsy with mental retardation locus on chromosome 8p. Genome Res 1997;7:887-96.
77. Haltia M, Tynnela J, Hirvasniemi A, Ylitalo MS, Herva R. Northern epilepsy: a novel form of neuronal ceroid lipofuscinosis. 7th Int Congr Neuronal Lipofuscinosis, 1998; Dallas, TX (Abstract O4).
78. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985;26:268-78.
79. Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 1978;61:720-7.
80. VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998;43:413-26.
81. Tsuboi T, Endo S. Genetic studies of febrile convulsions: analysis of twin and family data. Epilepsy Res 1991;4(suppl):119-28.
82. Corey LA, Berg K, Pellock JM, Solaas MH, Nance WE, DeLorenzo RJ. The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins. Neurology 1991;41:1433-6.
83. Rich SS, Annegers JF, Hauser WA, Anderson VE. Complex segregation analysis of febrile convulsions. Am J Hum Genet 1987; 41:249-57.
84. Wallace RH, Berkovic SF, Howell RA, Sutherland GR, Mulley JC. Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet 1996;33:308-12.
85. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogenous clinical phenotypes. Brain 1997;120:479-90.
86. 82a. Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999;45:75-81.
87. Maher J, McLachlan RS. Febrile convulsions in selected large families: a single-major-locus mode of inheritance? Dev Med Child Neurol 1997;39:79-84.
88. Johnson EW, Dubovsky J, Rich SS, et al. Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet 1998;7:63-7.
89. +-channel β1 subunit gene SCN1B. Nat Genet 1998;19:366-70.
90. Kugler SL, Stenroos ES, Mandelbaum DE, et al. Hereditary febrile seizures: phenotype and evidence for a chromosome 19p locus. Am J Med Genet 1998;79:354-61.
91. Baram TZ, Gerth Z, Schultz L. Febrile seizures, an appropriate-aged model suitable for long-term studies. Dev Brain Res 1997;98:265-70.
92. Buchhalter JR. Inherited epilepsies of childhood. J Child Neurol 1994;9(suppl 1):S12-9.
93. Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Dev Brain Res 1991; 61:97-101.
94. Magloczky Z, Halasz P, Vajda J, Czirjak S, Freund TF. Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience 1997;76:377-85.
95. Stafstrom CE, Schwindt PC, Chubb MC, Crill WE. Properties of persistent sodium conductance and calcium conductance of layer V neurons from cat sensorimotor cortex in vitro. J Neurophysiol 1985;53:153-70.
96. Ryan SG. Partial epilepsy: chinks in the armour. Nat Genet 1995; 10:4-6.
97. Degen R, Degen HE. Some genetic aspects of rolandic epilepsy: waking and sleep EEGs in siblings. Epilepsia 1990;31:795-801.
98. Heijbel J, Blom S, Rasmuson M. Benign epilepsy of childhood with centrotemporal EEG foci: a genetic study. Epilepsia 1975;16:285-93.
99. Whitehouse W, Diebold U, Rees M, Parker K, Doose H, Gardiner RM. Exclusion of linkage of genetic focal sharp waves to the HLA region on chromosome 6p in families with benign partial epilepsy with centrotemporal sharp waves. Neuropediatrics 1993;24:208-10.
100. Rees M, Diebold U, Parker K, Doose H, Gardiner RM, Whitehouse WP. Benign childhood epilepsy with centrotemporal spikes and the focal sharp wave trait is not linked to the fragile X regions. Neuropediatrics 1993;24:211-3.
101. 96a. Neubauer BA, Fiedler B, Himmelein B, et al. Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14. Neurology 1998;51:1608-12.
102. 96b. Guerrini R, Bonanni P, Nardocci N, et al. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol 1999;45:344-52.
103. 4 subunit is associated with autosomal dominant noctural frontal lobe epilepsy. Nat Genet 1995;11:201-3.
104. Steinlein OK, Magnusson A, Stoodt J, et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant noctural frontal lobe epilepsy. Hum Mol Genet 1997;6:943-7.
105. 98a. Nakken KO, Magnusson A, Steinlein OK. Autosomal dominant noctural frontal lobe epilepsy: an electroclinical study of a Norwegian family with ten affected members. Epilepsia 1999;40: 88-92.
106. Phillips HA, Scheffer IE, Crossland KM, et al. Autosomal dominant noctural frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet 1998;63: 1101-9.
107. Segal M. Acetylcholine and epilepsy. In: Fisher RS, Coyle JT, eds. Neurotransmitters and epilepsy. New York: Wiley-Liss, 1991:95-101.
108. Weiland S, Witzemann V, Villarroel A, Propping P, Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett 1996;398:91-6.
109. 2 nicotinic acetylcholine receptors. J Neurosci 1997;17:9035-47.
110. Crespel A, Baldy-Moulinier M, Coubes P. The relationship between sleep and epilepsy in frontal and temporal lobe epilepsies: practical and physiopathologic considerations. Epilepsia 1998;39: 150-7.
111. Cendes F, Lopes-Cendes I, Andermann E, Andermann F. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 1998;50:554-7.
112. Ottman R, Risch N, Hauser WA, et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 1995;10:56-60.
113. 105a. Poza JJ, Saenz A, Martinez-Gil A, et al. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol 1999; 45:182-8.
114. Berkovic SF, McIntosh A, Howell RA, Mitchell A, Sheffield LJ, Hopper JL. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996;40:227-35.
115. King JT Jr, LaMotte CC. El mouse as a model of focal epilepsy: a review. Epilepsia 1989;30:257-65.
116. Poderycki M, Simoes J, Todorova M, Neumann P, Seyfried T. Environmental influences on epilepsy gene mapping in EL mice. J Neurogenet 1998;12:67-86.
117. Rise ML, Frankel WN, Coffin JM, Seyfried TN. Genes for epilepsy mapped in the mouse. Science 1991;253:669-73.
118. Scheffer IE, Bhatia KP, Lopes-Cendes I, et al. Autosomal dominant frontal epilepsy misdiagnosed as sheep disorder. Lancet 1994;343:515-7.
119. Malafosse A, Beck C, Bellet H, et al. Benign infantile familial convulsions are not an allelic form of the benign familial neonatal convulsions gene. Ann Neurol 1994;35:479-82.
120. Guipponi M, Rivier F, Vigevano F, et al. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997;6:473-7.
121. Szepetowski P, Rochette J, Berquin P, Piussan C, Lathrop GM, Monaco AP. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889-98.
122. Norio R, Koskiniemi M, Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet 1979;15:382-98.
123. Pennacchio LA, Lehesjoki AE, Stone NE, et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731-4.
124. Lalioti MD, Scott HS, Antonarakis SE. What is expanded in progressive myoclonus epilepsy? Nat Genet 1997;17:17.
125. Lalioti MD, Scott HS, Genton P, et al. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am J Hum Genet 1998;62:842-7.
126. Pennachio L, Higgins K, Scott M, Myers R. Towards an animal model for progressive myoclonic epilepsy (EPM1). Epilepsia 1997;38(suppl 8):122.
127. Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, Myers RM. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 1998;20:251-8.
128. Lehesjoki AE, Koskiniemi M, Pandolfo M, et al. Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's diseases. Neurology 1992;42:1545-50.
129. Berkovic SF, Cochius J, Andermann E, Andermann F. Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia 1993;34(suppl 3):S19-30.
130. Serratosa JM, Delgado-Escueta AV, Posada I, et al. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet 1995;4:1657-63.
131. Minassian B, Lee J, Herbrick J, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonic epilepsy. Nat Genet 1998;20:171-4.
132. Pshezhetsky AV, Richard C, Michaud L, et al. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet 1997; 15:316-20.
133. Goebel HH. The neuronal ceroid-lipofuscinoses. Semin Pediatr Neurol 1996;3:270-8.
134. Boustany RM. Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types. Am J Med Genet 1992;42:533-5.
135. Boustany R. Batten disease. In: Vinken, Bruyn, eds. Handbook of clinical neurology, Vol. 66. Amsterdam: Elsevier, 1996:671-700.
136. Vesa J, Hellsten E. Verkruyse LA, et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995;376:584-7.
137. Sharp JD, Wheeler RB, Lake BD, et al. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum Mol Genet 1997;6:59-5.
138. Sleat DE, Donnelly RJ, Lackland H, et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997;277:1802-5.
139. Lerner TJ, Boustany R-MN, Anderson JW, et al. (The International Batten Disease Consortium). Isolation of a novel gene underlying Batten disease. CLN3. Cell 1995;82:949-57.
140. Jarvela I, Sainio M, Rantamaki T, et al. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Hum Mol Genet 1998;7:85-90.
141. Munroe PB, Mitchison HM, O'Rawe AM, et al. Spectrum of mutations in the Batten disease gene, CLN3, Am J Hum Genet 1997;61:310-6.
142. Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat Genet 1998;19:286-8.
143. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990;61:931-7.
144. Wallace DC, Lott MT, Shoffner JM, Ballinger S. Mitochondrial DNA mutations in epilepsy and neurological disease. Epilepsia 1994;35(suppl 1):S43-50.
145. Silvestri G, Moracs CT, Shanske S, Oh SJ, DiMauro S. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992;51:1213-7.
146. Burke JR, Enghild JJ, Martin ME, et al. Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-50.
147. Ross CA, Becher MW, Colomer V, Engelender S, Wood JD, Sharp AH. Huntington's disease and dentatorubralpallidoluysian atrophy: proteins, pathogenesis and pathology. Brain Pathol 1997;7:1003-16.
148. Farrell K. Classifying epileptic syndromes: problems and a neurobiologic solution. Neurology 1993;43(suppl 5):S8-11.
149. Kotagal P, Rothner AD. Epilepsy in the setting of neurocutaneous syndromes. Epilepsia 1993;34(suppl 3):S71-8.
150. Curatolo P. Tuberous sclerosis. In: Dulac O, Chugani HT, Dalla Bernardina B, eds. Infantile spasms and West syndrome. London: Saunders, 1994:192-202.
151. Sampson JR, Harris PC. The molecular genetics of tuberous sclerosis. Hum Mol Genet 1994;3:1477-80.
152. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-8.
153. Kandt RS, Haines JL, Smith M, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992;2:37-41.
154. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap1GAP activity. J Biol Chem 1995;270:16409-14.
155. Wienecke R, Maize JC Jr, Reed JA, de Gunzburg J, Yeung RS, DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 1997;150:43-50.
156. Dobyns WB, Reiner O, Carrozzo R, Ledbetter DH. Lissencephaly: a human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. JAMA 1993;270: 2838-42.
157. Chong SS, Pack SD, Roschke AV, et al. A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum Mol Genet 1997;6:147-55.
158. Hattori M, Adachi H, Tsuijimoto M, Arai H, Inoue K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature 1994;370:216-8.
159. Bazan NG, Packard MG, Teather L, Allan G. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem Int 1997;30:225-31.
160. Reiner O, Albrecht U, Gordon M, et al. Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migration. J Neurosci 1995;15:3730-8.
161. 2+ in hippocampal neurons. Neuron 1992;9;285-94.
162. Hirotsune S, Fleck MW, Gambello MJ, et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet 1998;19:333-9.
163. Ross ME, Allen KM, Srivastava AK, et al. Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain. Hum Mol Genet 1997;6:555-62.
164. des Portes V, Pinard JM, Billuart P, et al. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 1998;92:51-61.
165. Gleeson JG, Allen KM, Fox JW, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998;92:63-72.
166. Kamuro K, Tenokuchi Y. Familial periventricular nodular heterotopia. Brain Dev 1993;15:237-41.
167. Dubeau F, Tampieri D, Lee N, et al. Periventricular and subcortical nodular heterotopia: a study of 33 patients. Brain 1995;118: 1273-87.
168. Battaglia G, Granata T, Farina L, D'Incerti L, Franceschetti S, Avanzini G. Periventricular nodular heterotopia: epileptogenic findings. Epilepsia 1997;38:1173-82.
169. Jardine PE, Clarke MA, Super M. Familial bilateral periventricular nodular heterotopia mimics tuberous sclerosis. Arch Dis Child 1996;74:244-6.
170. Huttenlocher PR, Taravath S, Mojtahedi S. Periventricular heterotopia and epilepsy. Neurology 1994;44:51-5.
171. Eksioglu YZ, Scheffer IE, Cardenas P, et al. Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron 1996;16:77-87.
172. Jacobs KM, Gutnick MJ, Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cereb Cortex 1996;6:514-23.
173. Flint AC, Kriegstein AR. Mechanism underlying neuronal migration disorders and epilepsy. Curr Opin Neurol 1997:10:92-7.
174. Caviness VS Jr, Rakic P, Mechanism of cortical development: a view from mutations in mice. Annu Rev Neurosci 1978;1:297-326.
175. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995;374:719-23.
176. Sheldon M, Rice DS, D'Arcangelo G, et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 1997;389:730-3.
177. Ware ML, Fox JW, Gonzalez JL, et al. Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron 1997;19:239-49.
178. Lee KS, Schottler F, Collins JL, et al. A genetic animal model of human neocortical heterotopia associated with seizures. J Neurosci 1997;17:6236-42.
179. Lee KS, Collins JL, Anzivino MJ, Frankel EA, Schottler F. Heterotopic neurogenesis in a rat with cortical heterotopia. J Neurosci 1998;18:9365-75.
180. Guerrini R, Gobbi G, Genton P, Bonnani P, Carrazo R. Chromosomal abnormalities. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1998; 2533-46.
181. Wisniewski KE, French JH, Fernando S, et al. Fragile X syndrome associated neurological abnormalities and developmental disabilities. Ann Neurol 1985;18:665-9.
182. Musumeci SA, Colognola RM, Ferri R, et al. Fragile-X syndrome: a particular epileptogenic EEG pattern. Epilepsia 1988; 29:41-7.
183. Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD. The Fra(X) syndrome; neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 1991; 38:476-80.
184. Kluger G, Bohm I, Laub MC, Waldenmaier C. Epilepsy and fragile X gene mutations. Pediatr Neurol 1996;15:358-60.
185. Bakker CE, Verheij C, Willemsen R, et al. Fmr1 knockout mice: a model to study fragile X mental retardation: the Dutch-Belgian Fragile X Consortium. Cell 1994;78:23-33.
186. Angelman H. "Puppet" children: a report of three cases. Dev Med Child Neurol 1965;7:681-7.
187. Viani F, Romeo A, Viri M, et al. Seizures and EEG patterns in Angelman's syndrome. J Child Neurol 1995;10:467-71.
188. Minassian BA, DeLorey TM, Olsen RW, et al. Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 1998;43:485-93.
189. Sugimoto T, Yasuhara A, Ohta T, et al. Angelman syndrome in three siblings: characteristic epileptic seizures and EEG abnormalities. Epilepsia 1992;33:1078-82.
190. Matsumoto A, Kumagai T, Miura K, Miyazaki S, Hayakawa C, Yamanaka T. Epilepsy in Angelman syndrome associated with chromosome 15q deletion. Epilepsia 1992;33:1083-90.
191. Boyd SG, Harden A, Patton MA. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 1988;147: 508-13.
192. Laan LA, Renier WO, Arts WF, et al. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia 1997;38:195-9.
193. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997;15:70-3.
194. A receptor beta 3 subunit to the Angelman/ Prader-Willi region of human chromosome 15. Am J Hum Genet 1991;49:330-7.
195. Sutcliffe JS, Jiang YH, Galijaard RJ, et al. The E6-AP ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res 1997;7:368-77.
196. Matsuura T, Sutcliffe JS, Fang P, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997;15:74-7.
197. Malzac P, Webber H, Moncla A, et al. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet 1998;62:1353-60.
198. 3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997;94:4143-8.
199. 3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998;18:8505-14.
200. 3 subunit knockout mice. Neurosci Lett 1998;240:81-4.
201. Cattanach BM, Barr JA, Beechey CV, Martin J, Noebels J, Jones J. A candidate model for Angelman syndrome in the mouse. Mamm Genome 1997;8:472-8.
202. Tatsuno M, Hayashi M, Iwamoto H, Suzuki Y, Kuroki Y. Epilepsy in childhood Down syndrome. Brain Dev 1984;6:37-44.
203. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol 1991;33:191-200.
204. Pueschel SM, Louis S, McKnight P. Seizure disorders in Down syndrome. Arch Neurol 1991;48:318-20.
205. Veall RM, The prevalence of epilepsy among mongols related to age. J Ment Defic Res 1974;18:99-106.
206. Stafstrom CE, Kondol RJ. Infantile spasms in children with Down syndrome. Dev Med Child Neurol 1994;36:576-85.
207. Silva ML, Cieuta C, Guerrini R, Plouin P, Livet MO, Dulac O. Early clinical and EEG features of infantile spasms in Down syndrome. Epilepsia 1996;37:977-82.
208. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-53.
209. Evenhuis HM. The natural history of dementia in Down's syndrome. Arch Neurol 1990;47:263-7.
210. Ross MH, Galaburda AM, Kemper TL. Down's syndrome: is there a decreased population of neurons? Neurology 1984;34: 909-16.
211. Wisniewski KE, Laure-Kamionowska M, Wisniewski HM. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med 1984;311:1187-8.
212. Becker LE, Armstrong DL, Chan F. Dendritic atrophy in children with Down's syndrome. Ann Neurol 1986;20:520-6.
213. Stafstrom CE, Epilepsy in Down syndrome: clinical aspects and possible mechanisms. Am J Ment Retard 1993; 98(suppl):12-26.
214. Scott BS, Petit TL, Becker LE, Edwards BA. Abnormal electric membrane properties of Down's syndrome DRF neurons in cell culture. Brain Res 1981;254:257-70.
215. Caviedes P, Ault B, Rapoport SI. The role of altered sodium currents in action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (Down syndrome) human fetuses. Brain Res 1990;510:229-36.
216. Holtzman DM, Bayney RM, Li YW, et al. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J 1992;11:619-27.
217. Lacey-Casem ML, Oster-Granite ML. The neuropathology of the trisomy 16 mouse. Crit Rev Neurobiol 1994;8:293-322.
218. Ault B, Caviedes P, Rapoport SI. Neurophysiological abnormalities in cultured dorsal root ganglion neurons from the trisomy-16 mouse fetus, a model for Down syndrome. Brain Res 1989;485: 165-70.
219. Stoll J, Galdzicki Z. Reduced expression of voltage-gated sodium channels in neurons cultured from trisomy 16 mouse hippocampus. Int J Dev Neurosci 1996;14:749-60.
220. Reeves RH, Irving NG, Moran TH, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 1995;11:177-84.
221. Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z. Altered long-term potentiation in the young and old TS65Dn mouse, a model for Down syndrome. Neuropharmacology 1997;36:1549-54.
222. Korenberg JR, Kawashima H, Pulst SM, Allen L, Magenis E, Epstein CJ. Down syndrome: toward a molecular definition of the phenotype. Am J Med Genet Suppl 1990;7:91-7.
223. Colton CA, Yao JB, Gilbert D, Oster-Granite ML. Enhanced production of superoxide anion by microglia from trisomy 16 mice. Brain Res 1990;519:236-42.
224. Lehesjoki AE, Koskiniemi M, Sistonen P, et al. Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22. Proc Natl Acad Sci USA 1991;88:3696-9.
225. Eubanks JH, Puranam Rs, Kleckner NW, Bettler B, Heinemann SF, McNamara JO. The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1-22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1993;90:178-82.
226. Krishnamoorthy KS. Pyridoxine-dependency seizure: report of a rare presentation. Ann Neurol 1983;13:103-4.
227. Goutieres F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol 1985;17:117-20.
228. Scriver CR, Whelan DT. Glutamic acid decarboxylase (GAD) in mammalian tissue ouside the central nervous system, and its possible relevance to hereditary vitamin B6 dependency with seizures. Ann NY Acad Sci 1969;166:83-96.
229. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 1992:89: 2115-9.
230. 6. Nat Genet 1995;11:45-51.
231. Sutherland SJ, Olsen RD, Michels V, Schmidt MA, O'Brien JF. Screening for biotinidase deficiency in children with unexplained neurologic or developmental abnormalities. Clin Pediatr 1991; 30:81-4.
232. Wolf B, Heard GS. Biotinidase deficiency. Adv Pediatr 1991;38: 1-21.
233. Pomponio RJ, Reynolds TR, Cole H, Buck GA, Wolf B. Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency. Nat Genet 1995;11:96-8.
234. Pomponio RJ, Norrgard KJ, Hymes J, et al. Arg538 to Cys mutation in a CpG dinucleotide of the human biotinidase gene is the second most common cause of profound biotinidase deficiency in symptomatic children. Hum Genet 1997;99:506-12.
235. Norrgard KJ, Pomponio RJ, Swango KL, et al. Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. Biochem Mol Med 1997;61:22-7.
236. Huang F, Shi U, Heng HH, Fei J, Guo LH. Assignment of the human GABA transporter gene (GABATHG) locus to chromosome 3p24-p24. Genomics 1995;29:302-4.
237. Baumgartner R, Ando T, Nyhan WL. Nonketotic hyperglycinemia. J Pediatr 1969;75:1022-30.
238. Dalla Bernardina B, Dulac O, Fejerman N, et al. Early myoclonic epileptic encephalopathy (E.M.E.E.). Eur J Pediatr 1983;140: 248-52.
239. Garcia-Alvarez M, Nordli D, DeVivo D. Inherited metabolic diseases. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:2547-62.
240. Isobe M, Koyata H, Sakakibara T, Momoi-Isobe K, Hiraga K. Assignment of the true and processed genes for human glycine decarboxylase to 9p23-24 and 4q12. Biochem Biophys Res Commun 1994;203:1483-7.
241. Sato K, Yoshida S, Fujiwara K, Tada K, Tohyama M. Glycine cleavage system in astrocytes. Brain Res 1991;567:64-70.
242. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-31.
243. Kure S, Tada K, Narisawa K. Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects. Jpn J Hum Genet 1997;42:13-22.
244. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990:348:651-3.
245. Shoffner JM, Bialer MG, Pavlakis SG, et al. Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNALeu(UUR) gene. Neurology 1995; 45:286-92.
246. Morgan-Hughes JA, Sweeney MG, Cooper JM, et al. Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype. Biochim Biophys Acta 1995;1271:135-40.
247. Lombardo AJ, Kuzniecky R, Powers RE, Brown GB. Altered brain sodium channel transcript levels in human epilepsy. Mol Brain Res 1996;35:84-90.
248. Smart SL, Lopantsev V, Zhang CL, et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998;20:809-19.
249. Francis J, Jugloff DG, Mingo NS, et al. Kainic acid-induced generalized seizures alter the regional hippocampal expression of the rat Kv4.2 potassium channel gene. Neurosci Lett 1997;232: 91-4.
250. + channel GIRK2. Proc Natl Acad Sci USA 1997;94:923-7.
251. Rosahl TW, Spillane D, Missler M, et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 1995; 375:488-93.
252. 2+/calmodulin-dependent kinase II α-subunit mutation. Proc Natl Acad Sci USA 1995;92:6852-5.
253. Matsumoto M, Nakagawa T, Inoue T, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol-1,4,5-triphosphate receptor. Nature 1996;379:168-71.
254. Brusa R, Zimmermann F, Koh DS, et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995;270:1677-80.
255. 2c serotonin receptors. Nature 1995;374: 542-6.
256. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16: 675-86.
257. Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997;276:1699-702.
258. Aigner L, Arber S, Kapfhammer JP, et al. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 1995;83: 269-78.
259. Kagawa T, Ikenaka K, Inoue Y, et al. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 1994:;13:427-42.
260. Acampora D, Mazan S, Avantaggiato V, et al. Epilepsy and brain abnormalities in mice lacking the Otx1 gene. Nat Genet 1996; 14:218-22.
261. Noebels J. Epilepsy genes make their entrance. AES News 1998; 6:1-3.
262. Liu AW, Delgado-Escueta AV, Serratosa JM, et al. Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait. Am J Hum Genet 1995;57:368-81.
263. Weissbecker KA, Durner M, Janz D, Scaramelli A, Sparkes RS, Spence MA. Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. Am J Med Genet 1991;38:32-6.
264. Serratosa JM, Delgado-Escueta AV, Medina MT, Zhang Q, Iranmanesh R, Sparkes RS. Clinical and genetic analysis of a large pedigree with juvenile myoclonic epilepsy. Ann Neurol 1996;39: 187-95.
265. Ranta S, Lehoesjoki AE, Hirvasniemi A, et al. Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p. Genome Res 1996;6:351-60.
266. Lewis TB, Wood S, Michaelis EK, DuPont BR, Leach RJ. Localization of a gene for a glutamate binding subunit of a NMDA receptor (GRINA) to 8p24. Genomics 1996; 32:131-3.
267. Toth M, Grimsby J, Buzsaki G, Donovan GP. Epileptic seizures caused by inactivation of a novel gene, jerky, related to centro-mere binding protein-B in transgenic mice. Nat Genet 1995;11: 71-5.
268. 3 subunit gene cluster on chromosome 15. Acta Neurol Scand 1997;96:1-7.
269. Phillips HA, Scheffer IE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet 1995;10:117-8.
270. Phillips HA, Hulley JC. SSCP variants within the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor gene. Clin Genet 1997;51:135-6.
271. Green AJ, Johnson PH, Yates JR. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994;3:1833-4.
272. Srivastava AK, Ross ME, Allen KM, et al. X-linked lissencephaly and SBH (XLIS): mapping of a novel neuronal migration gene. Am J Hum Genet 1996;59(suppl):A55.
273. Reiner O, Carrozzo R, Shen Y, et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature 1993;364:717-21.
274. Korenberg JR. Toward a molecular understanding of Down syndrome. Prog Clin Biol Res 1993;384:87-115.
275. Korenberg JR. Mental modelling. Nat Genet 1995;11:109-11.
276. Sgro V, Riva E, Canevini MP, et al. 4p(-) syndrome: a chromosomal disorder associated with a particular EEG pattern. Epilepsia 1995;36:1206-14.
277. Altherr Mr, Wright TJ, Denison K, Perez-Castro AV, Johnson VP. Delimiting the Wolf-Hirschhorn syndrome critical region to 750 kilobase pairs. Am J Med Genet 1997;71:47-53.
278. Guerrini R, Bureau M, Mattei MG, Battaglia A, Galland MC, Roger J. Trisomy 12p syndrome: a chromosomal disorder associated with generalized 3-Hz spike and wave discharges. Epilepsia 1990;31:557-66.
279. Bundey S, Hardy C, Vickers S, Kilpatrick MW, Corbett JA. Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol 1994;36:736-42.
280. Battaglia A, Gurrieri F, Bertini E, et al. The inv dup(15) syndrome: a clinically recognizable syndrome with altered behavior, mental retardation, and epilepsy. Neurology 1997;48:1081-6.
281. Inoue Y, Fujiwara T, Matsuda K, et al. Ring chromosome 20 and nonconvulsive status epilepticus: a new epileptic syndrome. Brain 1997;120:939-53.
282. Pennacchio LA, Myers RM. Isolation and characterization of the mouse cystatin B gene. Genome Res 1996;6:1103-9.
283. Virtaneva K, D'Amato E, Miao J, et al. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997;15:393-6.
284. Tsuji S, Choudary PV, Martin BM, et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med 1987;316:570-5.
285. Bonten E, van der Spoel A, Fornerod M, Grosveld G, d'Azzo A. Characterization of human lysosomal neuraminidase defines the moldecular basis of the metabolic storage disorder sialidosis. Genes Dev 1996;10:3156-69.
286. Hayasaka K, Tada K, Fueki N, et al. Nonketotic hyperglycinemia: analyses of glycine cleavage system in typical and atypical cases. J Pediatr 1987;110:873-7.
287. McNamara JO, Eubanks JH, McPherson JD, Wasmuth JJ, Evans GA, Heinemann SF. Chromosomal localization of human glutamate receptor genes. J Neurosci 1992;12:2555-62.
288. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-51.
289. McNamara JO, Patel M, He XP, Janumpalli S, Whitney KD. Glutamate receptor autoimmunity in Rasmussen's encephalitis. Cold Spring Harb Symp Quant Biol 1996;61:327-32.
290. Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:1-6.
291. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995;11: 126-9.
292. Donovan GP, Harden C, Gal J, et al. Sensitivity to jerky gene dosage underlies epileptic seizures in mice. J Neurosci 1997;17: 4562-9.
293. Kokaia M, Ernfors P, Kokaia Z, Elmer E, Jaenisch R, Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 1995;133:215-24.
294. Tsirka SE, Gualandris A, Amaral DG, Strickland S, Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995;377:340-4.
295. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD. Knock-out mice reveal a critical antiepileptic role for neuropeptide. Y. J Neurosci 1997;17:8927-36.
296. Krawczak M, Cooper DN. The human gene mutation database. Trend Genet 1997;13:121-2.